Description: EchoIQ Limited provides cardiac diagnostics technology solution in Australia. The company's artificial intelligence-assisted diagnostics technology supports the sensitive diagnosis of Aortic Stenosis. It primarily serves device manufacturers, cardio scanning equipment, pharmaceuticals, and healthcare providers and insurers, as well as clinicians and patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. EchoIQ Limited is based in St Leonards, Australia.
Home Page: www.echoiq.ai
EIQ Technical Analysis
88 William Street
Perth,
WA
6000
Australia
Phone:
61 2 9159 3719
Officers
| Name | Title |
|---|---|
| Mr. Andrew Grover | Interim MD & Exec. Chairman |
| Jacki McAvenna | Chief Financial Officer |
| Mr. Philip Woolff | Chief Operating Officer |
| Sean Bryceland | Chief Technology Officer |
| Prof. David Playford | Chief Medical Officer- Medical Advisory Team |
| Mr. Donald L. Fowler | Pres of Echo IQ USA |
| Ms. Jessamyn Sarah Lyons AGIA, B.Com. | Joint Company Secreatry |
| Adam Uren | Joint Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 11.3415 |
| Price-to-Sales TTM: | 371.2913 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |